tiprankstipranks
Trending News
More News >

Beth Seidenberg Insider Profile

3,602 Followers
Beth Seidenberg, Director at Epizyme, holds 4.67M shares in Kyverna Therapeutics, Inc. (Ticker: KYTX), holds 0.00 shares in ACELYRIN, INC. (Ticker: SLRN), holds 135.56K shares in Vera Therapeutics (Ticker: VERA). Most recently, Beth Seidenberg Bought ― shares of Kyverna Therapeutics, Inc. on Dec 22, 2025 for an estimated value of $1000.00K.
tipranks
Beth Seidenberg

Beth Seidenberg
Epizyme (EPZM)
Director

Ranked #9 out of 105,518 Corporate Insiders

Profitable Transactions

89%
16 out of 18 Profitable Transactions

Average Return

+348.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$203M
64.55%
19.24%
6.14%
4.46%
5.61% Others
A breakdown of Beth Seidenberg's holdings

Insider Roles

Progyny
(PGNY)
Director
Kyverna Therapeutics, Inc.
(KYTX)
Director
Sagimet Biosciences, Inc. Class A
(SGMT)
Director
Atara Biotherapeutics
(ATRA)
Director
+3 other positions
Roles that Beth Seidenberg holds in companies

Most Profitable Insider Trade

Stock:
Atara Biotherapeutics
(ATRA)
Rating:Informative Buy
Date:Oct 15, 2014 - Oct 15, 2015
Return:+800.00%
The most profitable trade made by Beth Seidenberg

Beth Seidenberg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EPZM
Epizyme
Jun 07, 2019
Uninformative Buy
12.69K
$6.06M
ARMO
Armo Biosciences Inc
Jun 22, 2018
Uninformative Sell
213.33M
$0.00
Progyny
May 28, 2024
Director
Uninformative Buy
$131.08M
Vera Therapeutics
Oct 30, 2024
Director
Uninformative Sell
720.46K
$6.31M
SLRN
ACELYRIN, INC.
May 23, 2025
Uninformative Sell
$0.00
Sagimet Biosciences, Inc. Class A
Jul 20, 2023
Director
Uninformative Buy
$12.47M
Kyverna Therapeutics, Inc.
Dec 22, 2025
Director
Informative Buy
1000.00K
$39.07M
TSRO
Tesaro
Jan 24, 2019
Uninformative Sell
166.66M
$0.00
Atara Biotherapeutics
Jun 02, 2023
Director
Uninformative Buy
$9.05M
Amgen
Sr VP, Dev & Chief Medical Ofc
$5.07M
BioCryst
Director
$19.98K
List of latest transactions for each holding click on a transaction to see Beth Seidenberg's performance on stock

Beth Seidenberg insider profile FAQ

What is the percentage of profitable transactions made by Beth Seidenberg?
The percentage of profitable transactions made by Beth Seidenberg is 89%.
    What is the average return per transaction made by Beth Seidenberg?
    The average return per transaction made by Beth Seidenberg is 348.00%.
      What stocks does Beth Seidenberg hold?
      Beth Seidenberg holds: EPZM, ARMO, PGNY, VERA, SLRN, SGMT, KYTX, TSRO, ATRA, AMGN, BCRX stocks.
        What was Beth Seidenberg’s latest transaction?
        Beth Seidenberg latest transaction was an Informative Buy of $1000.00K.
          What was Beth Seidenberg's most profitable transaction?
          Beth Seidenberg’s most profitable transaction was an Informative Buy of ATRA stock on October 15, 2014. The return on the trade was 800.00%.
            What is Beth Seidenberg's role in Epizyme?
            Beth Seidenberg's role in Epizyme is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.